Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHA2 | P29317 | 2/20 | 0.60 |
| ▸ | OPRM1 | P35372 | 6/20 | 0.57 |
| ▸ | OPRD1 | P41143 | 4/20 | 0.57 |
| ▸ | NMUR2 | Q9GZQ4 | 5/20 | 0.57 |
| ▸ | NMUR1 | Q9HB89 | 5/20 | 0.57 |
| ▸ | CXCR4 | P61073 | 2/20 | 0.56 |
| ▸ | OPRK1 | P41145 | 2/20 | 0.53 |
| ▸ | RAMP3 | O60896 | 4/20 | 0.52 |
| ▸ | CALCR | P30988 | 4/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31688331 | 0.90 | APLNR (0.58) | EPHA2NMUR2NMUR1CXCR4 | |
| SCHEMBL30498507 | 0.89 | EPHA2 (0.60) | EPHA2OPRM1NMUR2NMUR1OPRK1 | |
| SCHEMBL32670411 | 0.88 | EPHA2 (0.68) | EPHA2OPRM1OPRD1NMUR2NMUR1 | |
| SCHEMBL30498506 | 0.87 | EPHA2 (0.58) | EPHA2OPRM1NMUR2NMUR1OPRK1 | |
| SCHEMBL30576961 | 0.87 | RAMP3 (0.59) | CXCR4RAMP3CALCR | |
| SCHEMBL30974058 | 0.87 | EPHA2 (0.60) | EPHA2NMUR2NMUR1RAMP3CALCR | |
| SCHEMBL31688345 | 0.87 | NMUR2 (0.64) | NMUR2NMUR1RAMP3CALCR | |
| SCHEMBL29366560 | 0.86 | NMUR2 (0.59) | OPRM1OPRD1NMUR2NMUR1OPRK1 | |
| SCHEMBL30335928 | 0.86 | EPHA2 (0.68) | EPHA2OPRM1OPRD1NMUR2NMUR1 | |
| SCHEMBL30327403 | 0.86 | EPHA2 (0.68) | EPHA2OPRM1OPRD1NMUR2NMUR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122060057-A | Clara cell protein antibody or antigen binding fragment and application thereof | 天津博奥赛斯生物科技股份有限公司 | 2026-05-19 | — | — | CN | disclosed |